United States HR 9077: To direct the Director of the National Institutes of Health and the Secretary of Health and Human Services to evaluate hormone variability and hormone testing, respectively, in women with respect to perimenopause.

Status: Introduced in House (as of 2026-05-29)

State: United States · Session: 119 · Bill: HR 9077

Sponsors: Hillary J. Scholten

View United States HR 9077 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.